Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: For patients who have a ventricular tachyarrhythmic event, implantable cardioverter-defibrillators (ICDs) are a mainstay of therapy to prevent sudden death. However, ICD shocks are painful, can result in clinical depression, and do not offer complete protection against death from arrhythmia. We designed this randomized trial to examine whether prophylactic radiofrequency catheter ablation of arrhythmogenic ventricular tissue would reduce the incidence of ICD therapy. METHODS: Eligible patients with a history of a myocardial infarction underwent defibrillator implantation for spontaneous ventricular tachycardia or fibrillation. The patients did not receive antiarrhythmic drugs. Patients were randomly assigned to defibrillator implantation alone or defibrillator implantation with adjunctive catheter ablation (64 patients in each group). Ablation was performed with the use of a substrate-based approach in which the myocardial scar is mapped and ablated while the heart remains predominantly in sinus rhythm. The primary end point was survival free from any appropriate ICD therapy. RESULTS: The mortality rate 30 days after ablation was zero, and there were no significant changes in ventricular function or functional class during the mean (+/-SD) follow-up period of 22.5+/-5.5 months. Twenty-one patients assigned to defibrillator implantation alone (33%) and eight patients assigned to defibrillator implantation plus ablation (12%) received appropriate ICD therapy (antitachycardia pacing or shocks) (hazard ratio in the ablation group, 0.35; 95% confidence interval, 0.15 to 0.78, P=0.007). Among these patients, 20 in the control group (31%) and 6 in the ablation group (9%) received shocks (P=0.003). Mortality was not increased in the group assigned to ablation as compared with the control group (9% vs. 17%, P=0.29). CONCLUSIONS: In this randomized trial, prophylactic substrate-based catheter ablation reduced the incidence of ICD therapy in patients with a history of myocardial infarction who received ICDs for the secondary prevention of sudden death. (Current Controlled Trials number, ISRCTN62488166 [controlled-trials.com].).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia (SMASH-VT) trial, 30 which randomly assigned 128 ICD patients with a history of ventricular arrhythmia and myocardial infarction to ablation or usual care, arrhythmia recurrence was significantly decreased from 33% to 12% with ablation.”
From Managing with pacemakers and implantable cardioverter defibrillators (2013) · cites this paper as [30]
Citations
Cites
(1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,232
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041489 · Cited by 1,519
Marchlinski, F. E., Callans, D. J., Gottlieb, C. D., & Zado, E. (2000) · Circulation · doi:10.1161/01.cir.101.11.1288 · Cited by 1,220
Moss, A. J., Greenberg, H., Case, R. B., Zareba, W., Hall, W. J., Brown, M. W., Daubert, J. P., McNitt, S., Andrews, M. L., & Elkin, A. D. (2004) · Circulation · doi:10.1161/01.cir.0000150390.04704.b7 · Cited by 597
Prevention of Implantable-Defibrillator Shocks by Treatment with Sotalol
Pacifico, A., Hohnloser, S. H., Williams, J. H., Tao, B., Saksena, S., Henry, P. D., & Prystowsky, E. N. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402402 · Cited by 422
Guiraudon, G., Fontaine, G., Frank, R., Escande, G., Etievent, P., & Cabrol, C. (1978) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)62923-2 · Cited by 404
Electrical storm in patients with transvenous implantable cardioverter-defibrillators
Credner, S. C., Klingenheben, T., Mauss, O., Sticherling, C., & Hohnloser, S. H. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00495-1 · Cited by 376
Arenal, A., Glez-Torrecilla, E., Ortiz, M., Villacastín, J., Fdez-Portales, J., Sousa, E., del Castillo, S., Perez de Isla, L., Jimenez, J., & Almendral, J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02623-2 · Cited by 343
Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies
Goldberger, Z., & Lampert, R. (2006) · JAMA · doi:10.1001/jama.295.7.809 · Cited by 271
Research works printed but not linked: 1
- Stevenson WG, 2005, Curr Opin Cardiol, 20, 42
Cited by
Items 701–800 of 964
Image‐Guided Electrophysiology Mapping and Ablation
Dickfeld, T.-M. L. (2010) · Wiley eBooks · doi:10.1002/9781444323894.ch14 · Cited by 1
Antiarrhythmic Drug Therapy for New-Onset Ventricular Arrhythmia (VT/VF) in ICD Patients
Nair, G. M., Healey, J. S., Divakaramenon, S., Connolly, S. J., & Morillo, C. A. (2011) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2011.08.009 · Cited by 1
Kapa, S., & Hutchinson, M. D. (2012) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2012.02.006 · Cited by 1
Radio frequency ablation for VT – A cost-effective tool to combat SCD in developing countries
Nair, M., & Patra, S. K. (2013) · Indian Heart Journal · doi:10.1016/j.ihj.2013.11.005 · Cited by 1
Spinal cord stimulators for treatment of ventricular arrhythmias: Antiarrhythmic in a can
Nanthakumar, K. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.02.011 · Cited by 1
Iron-Overload-Related Disease in HFE Hereditary Hemochromatosis
Pedersen, O. B., Gæde, P., Vedel, P. N., Forastiere, F., Valente, P., & Zuccaro, P. (2008) · Cited by 1
Ventricular Tachycardia Ablation—For Whom, When, and How?
Barrett, C. D., Biase, L. D., Vacca, M. A., Sáenz, L. C., Burkhardt, J. D., Ruskin, J. N., & Natale, A. (2009) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2009.08.003 · Cited by 1
Self-citationESC-Leitlinien 2015 zu ventrikulären Arrhythmien und zur Prävention des plötzlichen Herztodes
Fink, T., Kück, K., & Metzner, A. (2015) · Herz · doi:10.1007/s00059-015-4380-6 · Cited by 1
Ablation ventrikulärer Arrhythmien
Wasmer, K., & Eckardt, L. (2015) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-015-0403-5 · Cited by 1
A Primer on Cardiac Devices: Psychological and Pharmacological Considerations
Ng, C. Y., & Mela, T. (2016) · Psychiatric Annals · doi:10.3928/00485713-20161107-01 · Cited by 2
Complex management of electrical storm in a patient with non-ischemic dilated cardiomyopathy
Mitu, O., Balasanian, M., Stătescu, C., Grecu, M., Dabija, A., Iovoaia, A., Strimbeanu, E., & Georgescu, C. A. (2017) · Archive of Clinical Cases · doi:10.22551/2017.15.0402.10103 · Cited by 1
Ventricular Tachycardia and Fibrillation in Patients with Structural Heart Disease
Mitrani, R. D., & Myerburg, R. J. (2017) · Cardiovascular medicine · doi:10.1007/978-3-319-58000-5_16 · Cited by 1
Boles, U., Gül, E. E., Fitzgerald, L. M., Ali, F. S., Nolan, C., Aldworth-Gaumond, K., Redfearn, D. R., Baranchuk, A. M., Glover, B. M., Simpson, C., et al. (2017) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2017.10.010 · Cited by 1
“Measures to reduce inappropriate shocks, including an empiric ablative strategy, have been shown to reduce morbidity [3].”
BackgroundStatistical guidance of VT ablation
Rodrigo, M., & Narayan, S. M. (2018) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13633 · Cited by 1
Management of Arrhythmias in Heart Failure
Podrid, P. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10053-1 · Cited by 1
Postinfarction Sustained Monomorphic Ventricular Tachycardia
Issa, Z. F., Miller, J. M., & Zipes, D. P. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5998-1.00021-5 · Cited by 1
Device Therapy in the Heart Failure
Rhodes, T. E., & Weiss, R. (2019) · Cardiovascular medicine · doi:10.1007/978-3-319-98184-0_9 · Cited by 1
2018 KHRS Guidelines for Catheter Ablation of Ventricular Arrhythmias – Part1
Roh, S., Kim, S., Kim, Y.-N., Kim, J.-Y., Kim, J., Kim, T., Nam, G., Park, K., Park, H., Pak, H., et al. (2018) · International Journal of Arrhythmia · doi:10.18501/arrhythmia.2018.006 · Cited by 1
Berruezo, A., Fernández‐Armenta, J., Penela, D., Acosta, J., Brugada, J., Mont, L., & Jáuregui, B. (2019) · Wiley eBooks · doi:10.1002/9781119152637.ch83 · Cited by 1
Role of catheter ablation in the treatment of scar-related ventricular tachycardia
Mamchur, S. E., Chichkova, T. Y., Александрович, Х. Е., & Романова, М. П. (2019) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2019-8-4-93-102 · Cited by 1
“Основные данные, касающиеся этого вопроса, мы получили в исследованиях V-TACH и SMASH-VT [34, 35].”
Post-Infarction Sustained Monomorphic Ventricular Tachycardia
Issa, Z. F., Miller, J. M., & Zipes, D. P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-1274-8.00022-1 · Cited by 1
Streamlining Ventricular Tachycardia Ablation Workflow
Sapp, J. L. (2020) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.09.004 · Cited by 1
Lakkireddy, D. (2020) · Journal of Atrial Fibrillation · doi:10.4022/jafib.2371 · Cited by 1
Katritsis, D. G., & Morady, F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-79338-4.00025-x · Cited by 1
Zilinski, J. L., & Akhtar, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-52993-8.00023-0 · Cited by 1
Bogun, F. M., & Morady, F. (2020) · Springer eBooks · doi:10.1007/978-3-030-28328-5_16 · Cited by 1
Radinovic, A., & Bella, P. E. D. (2022) · Circulation · doi:10.1161/circulationaha.122.060914 · Cited by 1
Bénali, K., Guénancia, C., & Martins, R. P. (2022) · Circulation · doi:10.1161/circulationaha.122.060400 · Cited by 1
Best Practices for the Catheter Ablation of Ventricular Arrhythmias
Atreya, A. R., Yalagudri, S. D., Subramanian, M., Rangaswamy, V. V., Saggu, D. K., & Narasimhan, C. (2022) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2022.08.007 · Cited by 2
Bennett, R. G., Campbell, T. G., Garikapati, K., Kotake, Y., Turnbull, S., Kanawati, J., Wong, M. S., Qian, P. C., Thomas, S. P., Chow, C. K., et al. (2023) · Heart Lung and Circulation · doi:10.1016/j.hlc.2022.09.006 · Cited by 1
Gilge, J. L., Joshi, S. A., Nair, G. V., Clark, B. A., Prystowsky, E. N., & Patel, P. J. (2023) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15814 · Cited by 1
“For those that fail initial medical therapy, or those that are intolerant to medical therapy, catheter ablation (CA) of VA may reduce the frequency and morbidity associated with these arrhythmias.(7,8) Given that a considerable portion of sustained VA is unstable during the electrophysiology study (EPS), a substrate‐b…”
BackgroundKong, N., Shatz, D. Y., Besser, S. A., Upadhyay, G. A., & Tung, R. H. (2023) · Heart Rhythm O2 · doi:10.1016/j.hroo.2023.01.007 · Cited by 1
Cueva-Parra, Á., la Vega, D. N.-D., Yáñez-Guerrero, P., Bustillos-García, G. A., Gómez-Flores, J. R., Moisés Levinstein, J., Morales, J. L., Iturralde-Torres, P., Márquez, M. F., & Nava, S. (2022) · Archivos Peruanos de Cardiología y Cirugía Cardiovascular · doi:10.47487/apcyccv.v3i4.236 · Cited by 1
“Subsequent studies corroborated these findings and reaffirmed that catheter ablation reduces recurrence of VT (4,5) and also reduced the composite of mortality, hospitalizations, and discharges of the implantable cardioverter defibrillator (ICD) (6,7).”
ResultKatheterablation ventrikulärer Tachykardien – Update 2023
Bourier, F. J. (2023) · Herz · doi:10.1007/s00059-023-05167-5 · Cited by 1
Prasitlumkum, N., Chokesuwattanaskul, R., Kaewput, W., Thongprayoon, C., Cheungpasitporn, W., Jongnarangsin, K., & Nademanee, K. (2023) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16031 · Cited by 1
Self-citationИспользование различных подходов в лечении желудочковых нарушений ритма
Аванесян, Г. А., Филатов, А. Г., & Алиевич, Т. И. (2024) · Kreativnaya kardiologiya · doi:10.24022/1997-3187-2024-18-2-164-175 · Cited by 1
Ablation of Ventricular Tachycardia in Coronary Artery Disease
Haqqani, H. M., & Callans, D. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93110-6.00033-5 · Cited by 1
Sheagren, C. D., Escartin, T., Patel, J., Barry, J., & Wright, G. A. (2025) · Magnetic Resonance in Medicine · doi:10.1002/mrm.30468 · Cited by 1
Long-term outcome after multiple VT ablations in NICM patients
Müller, J., Chakarov, I., Halbfaß, P., Nentwich, K., Berkovitz, A., KOCH, L., Eichenlaub, M., Lehrmann, H., & Deneke, T. (2025) · Clinical Research in Cardiology · doi:10.1007/s00392-025-02649-w · Cited by 1
Katheterablation bei ventrikulärer Tachyarrhythmie
Parwani, A. S., Hohendanner, F., & Boldt, L. (2019) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-019-00653-y · Cited by 1
Báez-Escudero, J. L., & Valderrábano, M. (2009) · Elsevier eBooks · doi:10.1016/b978-032304525-4.00039-3 · Cited by 1
Ventricular Tachycardia Ablation: What Have We Learned From SMASH‐VT
Ellenbogen, K. A., & Kaszala, K. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01717.x · Cited by 1
Atwater, B. D., & Daubert, J. P. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01731.x · Cited by 1
Kück, K. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60381-9 · Cited by 1
Klein, L., & Knight, B. P. (2015) · Springer eBooks · doi:10.1007/978-1-4471-6657-3_7 · Cited by 1
Colella, A., Giaccardi, M., Lova, R. M., Liccardi, C., & Gensini, G. F. (2009) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-008-9351-x · Cited by 1
KATP vs Purkinje fibers: Which should we shoot first, or should we?
Kalyanasundaram, A., & Fedorov, V. V. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.08.028 · Cited by 1
Substrate based ablation of ventricular tachycardia through an epicardial approach.
Dm, A. M., Dm, A. T., Sridevi, C., Rao, B. H., Jaishankar, S., & Narasimhan, C. (2009) · PubMed Central · Cited by 1
Osteopenia: osteoporosis, osteomalacia and other forms of decreased mineralized bone mass.
Mundy, G. R., Canalis, E. M., & Raisz, L. G. (1976) · Connecticut medicine · Cited by 1
Aliot, E., & Brugada, J. (2010) · European Cardiology Review · doi:10.15420/ecr.2010.6.2suppl.8 · Cited by 1
Highlights of the Year in JACC2009
DeMaria, A. N., Bax, J. J., Ben‐Yehuda, O., Feld, G. K., Greenberg, B., Hall, J. L., Hlatky, M. A., Lew, W. Y. W., Lima, J. A. C., Maisel, A. S., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.007 · Cited by 1
“The mulicenter SMASH-VT (Substrate Mapping and Ablation in inus Rhythm to Halt Ventricular Tachycardia) trial (88) c emonstrated that ablation reduces the incidence of subseuent ICD therapy in patients with cardiomyopathy.”
Mark E Josephson: Clinical Investigator
Miller, J. M. (2017) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2017.6.1:ed3 · Cited by 1
Risk Factors for Early Mortality After VT Ablation
Sacher, F., & Martin, R. I. R. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.537 · Cited by 1
Additional Clarity Provided Through the Lens of CAMERA-MRI
Tzou, W. S. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.06.006 · Cited by 1
Preoperative imaging in search of ventricular tachycardia circuit
Yamashita, K., & Ranjan, R. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2018.11.012 · Cited by 1
Early Catheter Ablation for Unstable Ventricular Tachycardia: Still Too Early to Tell
Sapp, J. L., Parkash, R., & Wells, G. A. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.005110 · Cited by 1
“The observations in the trial provide a contrast with the 2 most directly comparable studies, the VTACH study(2) and the SMASH-VT trial (Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy).(3)”
ResultBilanovic, A. (2019) · YorkSpace (York University) · Cited by 1
Success after ventricular tachycardia ablation: All or nothing?
Daimee, U. A., & Berger, R. D. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.03.013 · Cited by 1
SALEEM, M. A., & Costanzo, M. R. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.01.051 · Cited by 1
Management of Complex Arrythmias: Optimal Timing of Catheter Ablation for Ventricular Tachycardia
Huntrakul, A., & Liang, J. J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175123 · Cited by 1
“The first large-scale randomized controlled trial (RCT) on early VT ablation was the Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia (SMASH-VT) study, published in 2007 [4].”
BackgroundDer Patient mit chronischer Herzinsuffizienz
Bänsch, D., & Grönefeld, G. (2010) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-010-0078-x · Cited by 1
ICD-Therapie zur Sekundärprävention
Seidl, K., Strauss, M., & Kleemann, T. (2010) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-010-0075-0 · Cited by 1
Programmed Stimulation During Mapping and Ablation of VT
Khaykin, Y. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5316-0_39
End-of-Life Care in Hospitalized Patients with Cardiovascular and Cerebrovascular Disease
Díez‐Villanueva, P., & Martínez‐Sellés, M. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6521-7_4
Aktuelle Strategien zur Vermeidung von ICD-Therapien
Vogler, J., Gosau, N., Moser, J. S., Hoffmann, B. A., & Willems, S. (2014) · Der Kardiologe · doi:10.1007/s12181-014-0605-9
Liew, R. (2012) · Український кардіологічний журнал
Estudo da interação do ultrassom com o tecido cardíaco
Buiochi, E. B. (2011) · doi:10.47749/t/unicamp.2011.827106
Indications to Ventricular Tachycardia/Ventricular Fibrillation Ablation and Hybrid Therapy
Prystowsky, E. N., BREITHARDT, G. E., Connolly, S. J., Kautzner, J., Lau, C., & Padanilam, B. J. (2009) · Wiley eBooks · doi:10.1002/9781444317077.ch13
Wang, Y. (2009) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7qf8qv5
Post‐Ventricular Tachycardia Ablation Follow‐Up Management
Ruskin, J. N., Verma, A., Borggrefe, M., Schalij, M. J., & Schweikert, R. A. (2009) · Wiley eBooks · doi:10.1002/9781444317077.ch11
Self-citationMapping Methods for Ventricular Tachycardia Ablation
Stevenson, W. G., Callans, D. J., d'Avila, A., Kottkamp, H., Sosa, E., & Yao, Y. (2009) · Wiley eBooks · doi:10.1002/9781444317077.ch6
Katheterablation bei elektrischem Sturm
Dechering, D. G., Frommeyer, G., Kochhäuser, S., & Eckardt, L. (2014) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-014-0309-7
Jiddou, M. R., & Haines, D. E. (2012) · Wiley eBooks · doi:10.1002/9781118481585.ch79
Colella, A., Giaccardi, M., Sabatini, A., Zuppiroli, A., & Franco, G. (2011) · InTech eBooks · doi:10.5772/22503
Management of Ventricular Arrhythmias: An Historical Perspective
Callans, D. J., & Josephson, M. E. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-161-5_1
“The approach to mapping and ablating the substrate involved finding potential channels of activation, which could form critical isthmuses responsible for arrhythmias within the scar ( 37 ).”
BackgroundSelf-citationElectromagnetic Mapping During Complex RF Ablations
Rosenheck, S., Banker, J., Weiss, A., & Sharo, Z. (2012) · InTech eBooks · doi:10.5772/30391
Electrical Storm in the Era of Implantable Cardioverter Defibrillators
David, T., & Traub, D. M. (2011) · InTech eBooks · doi:10.5772/22164
Mapping und Katheterablation von Kammertachykardien bei Patienten mit ischämischer Kardiomyopathie
Steven, D., Rostock, T., Hoffmann, B. A., Servatius, H., Müllerleile, K., Meinertz, T., & Willems, S. (2009) · Der Kardiologe · doi:10.1007/s12181-008-0156-z
Marchlinski, F. E., Themistoclakis, S., BURKHARDT, D. J., Saad, E., Sra, J., & Tondo, C. (2009) · Wiley eBooks · doi:10.1002/9781444317077.ch8
Caractéristiques et traitements des cicatrices myocardiques responsables d'arythmie ventriculaire
Sacher, F. (2014) · theses.fr (ABES) · doi:10.70675/94b5d3a4z28caz4d65z9f8dz7a5b466ccdeb
VT Ablation: Importance of Linear Lesions and Late Potentials
Pisani, C. F., de Melo, S. L., Hardy, C. A., & Scanavacca, M. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5316-0_38
Kuzmicic, B., Guillermo Castro, G., Felipe Gómez, N., & Carolina Espinoza, P. (2009) · Revista chilena de cardiología · doi:10.4067/s0718-85602009000200006
Nakahara, S., Hori, Y., Kamijima, T., Tsukada, N., Nishiyama, N., Yamada, K., Hayashi, A., Komatsu, T., Kobayashi, S., Sakai, Y., et al. (2014) · Journal of Arrhythmia · doi:10.1016/j.joa.2014.04.010
“Catheter ablation has been demonstrated to be an effective therapy for scar-mediated reentrant ventricular tachycardia (VT) and is being used prophylactically in the management of patients at risk for recurrent VT [1,2].”
BackgroundAblation von ventrikulären Rhythmusstörungen
Reents, T., & Deisenhofer, I. (2015) · CardioVasc · doi:10.1007/s15027-015-0536-9
Who needs a transplant and when?
Chan, W. X., & Ross, H. J. (2012) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283574185 · Cited by 1
“The Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia and Ventricular Tachycardia Ablation in Coronary Heart Disease trials examined the role of ‘preventive’ ventricular tachycardia ablation in patients with ischemic heart disease and showed a reduction in ventricular arrhythmias by about…”
BackgroundMethodBrigadeau, F., Kouakam, C., Boulé, S., Marquié, C., & Klug, D. (2010) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(10)70372-4
Wang, N. C., Piccini, J. P., Fonarow, G. C., Knight, B. P., Harinstein, M. E., Butler, J., Lahiri, M. K., Metra, M., Vaduganathan, M., & Gheorghiade, M. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.04.007
Catheter ablation for prevention of ventricular tachycardia
Tedrow, U. B., & Stevenson, W. G. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.17
“Ablation within areas of scar is strategically attractive, as these regions are less likely to contribute to ventricular contraction, and thus ablation in the scar does not appear to depress ventricular function”
Medikamentöse Therapie von Herzrhythmusstörungen
Koller, M. L., & Schumacher, B. (2010) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-010-1004-z
Muerte súbita cardiaca en las cardiopatías estructurales
Sarkozy, A., Chierchia, G., Rodríguez‐Mañero, M., & Brugada, P. (2013) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(13)70061-x · Cited by 5
Republished: The burden of inappropriate shocks in young people and how to avoid them
Upadhyay, G. A., Mela, T., & Singh, J. P. (2012) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2012-301861rep
Reducing ICD Shocks for Ventricular Arrhythmias
Schoenhard, J. A., & Zei, P. C. (2011) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2011.05.013
An implantable defibrillator and what else?
Mont, L., Guasch, E., & Berruezo, A. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp217
Acute Antiarrhythmic Therapy of Ventricular Tachycardia and Ventricular Fibrillation
Viswanathan, M. N., & Page, R. L. (2010) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2010.07.001
Recent Developments in the Ablation of Ventricular Arrhythmias
Schleifer, J. W., Mookadam, F., & Srivathsan, K. S. (2013) · Future Cardiology · doi:10.2217/fca.13.79
Noninvasive Imaging of Sinus Node Disease: Can It Predict the Need for Pacemaker Implantation?
Mulpuru, S. K., Schricker, A. A., & Narayan, S. M. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02159.x
Imaging Modalities in Cardiac Electrophysiology
Hasan, R., Clifford, S., Ghanbari, H., Schmidt, M. U., Segerson, N. M., & Daccarett, M. (2009) · Future Cardiology · doi:10.2217/fca.09.58 · Cited by 1
Liew, R. (2011) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2011.11.001
Niwano, S., Oikawa, J., & Fukaya, H. (2013) · Journal of Arrhythmia · doi:10.1016/j.joa.2013.05.003
“reported that prophylactic ablation would be effective in reducing the morbidity, but not mortality, of patients in a study designed as a randomized prospective study [17].”
BackgroundLearning To Breathe: Treatment of Sleep Disordered Breathing for ICD Shock Prevention
Bhave, P. D., & PASSMAN, R. S. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12224
Metadata
- Authors
- Reddy, V. Y., Reynolds, M. R., Neuzil, P., Richardson, A. W., Taborsky, M., Jongnarangsin, K., Kralovec, S., Sediva, L., Ruskin, J. N., & Josephson, M. E.
- Affiliations
- Massachusetts General Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-12-27
- Volume
- 357
- Issue
- 26
- Pages
- 2657-2665
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC2390777
- OpenAlex
- W2139803224
- Cited by
- 959
- References
- 28
- Citations by year
- 2026: 39 · 2025: 42 · 2024: 47 · 2023: 43 · 2022: 53 · 2021: 45 · 2020: 54 · 2019: 62 · 2018: 53 · 2017: 63 · 2016: 40 · 2015: 59 · 2014: 46 · 2013: 56 · 2012: 48
- FWCI
- 33.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K23 HL 68064, K23HL077171, K23HL068064)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- implantable cardioverter-defibrillator, ventricular tachyarrhythmia, myocardial infarction, sudden cardiac death, radiofrequency ablation, substrate-based ablation, myocardial scar, ICD shocks, secondary prevention
- MeSH terms
- Aged, Electric Countershock, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Ventricular Fibrillation, Multivariate Analysis, Death, Sudden, Cardiac, Catheter Ablation, Defibrillators, Implantable, Tachycardia, Ventricular, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.